StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Posted today on LinkedIn and X

<< Previous

Bullboard Posts

Next >>

Comment by Nailbiter2on Sep 17, 2023 4:43pm

320 Views

Post# 35640491

RE:RE:RE:Posted today on LinkedIn and X

Yes LL. Between the 2:56-3:20 marks is where Tripp
mentioned he would be transparent and name names.

If this happens on the November CC then we are turning around. More cause to believe him when he says he expects to be
cash-pos by the end of the year.

If Q4 shows profitability, then it's a different ball game.

I won't say squat until we find out who these
clinics and partners are.
And if we don't find out, well...
He deserves the harsh words coming to him.

Make it happen James.
It's been too long now.
Make it so.